Loading...
OTC Markets
Totals
Securities
12,242
Dollar Vol
$2.4B
Share Vol
3B
Trades
343,017

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

STEK
Stemtech Corp.

Common Stock

0.0217

-0.0023

-9.58%

0.0213 / 0.0216 (10000 x 230000)

Real-Time Best Bid & Ask: 05:00pm 08/22/2025
Delayed (15 Min) Trade Data: 12:00am 08/22/2025

Stemtech Corp.

4851 Tamiami Trail North

Suite 200

Naples, FL 34103

Business Description
Stemtech Corporation, a leading stemceutical™ company with a direct sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International, Inc., which was established in 2005. From 2010 through 2015, Stemtech International, Inc., was recognized four separate times on the Inc. 5000 Fastest-Growing Companies list. In 2018, Stemtech underwent an extensive executive reorganization, and continued operations under new leadership as Stemtech Corporation. In August 2021, Stemtech became a publicly traded company (OTCQB: STEK) and has expanded business opportunities for its Independent Business Partners, who may earn incomes by sharing Stemtech ...
More
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001511820
Fiscal Year End
12/31
Company Officers & Contacts
Charles S. Arnold
CEO

John W. Meyer
President, COO

Srilakshmi Vadlapatla
CFO

David E. Price
Corporate Secretary

Board of Directors
Charles S. Arnold
Chairman, CEO

Darryl V. Green
Independent Director, Audit Committee Member, Compensation Committee Member

Benjamin Kaplan
Independent Director, Compensation Committee Member

John W. Meyer

John Thatch
Independent Director, Audit Committee Member

Other Company Insiders
Jay Abbasi
Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Bush & Associates CPA
Securities Counsel
David E. Price, PC. - Bethesda, Maryland (USA)

#3 Bethesda Metro Center, Suite 700,

Bethesda, MD 20814

Profile Data
SIC - Industry Classification
5122 - Drugs, proprietaries, and sundries
Incorporation Information
NV, US, 2009
Employees
31 as of 06/30/2025
Shell
No
Products and Services

Stemtech offers our all-natural, plant-based RCM - release, circulate and migration nutritional (stemceutical™) supplement products, in addition to OraStem®, an all-natural toothpaste. In January 2023, Stemtech launched leading-edge proprietary blend, FDA approved ingredient, Cellect One® Rapid Renew Stem Cell Peptide Night Cream skincare product and Cellect One® Shield HOCL (Hypochlorous Acid) Mist. Stemtech also introduced StemPets™ nutritional supplement for dogs and cats in June 2025

Company Facilities

Stemtech has offices in countries where it conducts business and utilizes contract manufacturers under license from Stemtech to produce its products.

Company Notes
Formerly=Globe Net Wireless Corp. until 4-2022
OTCQB Venture Market Logo
Joined OTCQB 09/2024
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.